(April 1, 2020, 1:11 PM EDT) -- SILVER SPRING, Md. — The Food and Drug Administration on April 1 said it has asked all manufacturers to withdraw prescription and nonprescription ranitidine drugs from the market due to them developing high levels of N-nitrosodimethylamine (NDMA) contamination during storage....